The Immunogenicity of Adenovirus Vectors Limits the Multispecificity of CD8 T-cell Responses to Vector-encoded Transgenic Antigens
Open Access
- 30 September 2008
- journal article
- Published by Elsevier BV in Molecular Therapy
- Vol. 16 (9), 1609-1616
- https://doi.org/10.1038/mt.2008.141
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?The Journal of Experimental Medicine, 2008
- Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccinesBlood, 2007
- Effect of Preexisting Immunity to Adenovirus Human Serotype 5 Antigens on the Immune Responses of Nonhuman Primates to Vaccine Regimens Based on Human- or Chimpanzee-Derived Adenovirus VectorsJournal of Virology, 2007
- Relative dominance of epitope-specific CD8+ T cell responses in an F1 hybrid mouse model of respiratory syncytial virus infectionVirology, 2007
- Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV‐1 Candidate Vaccine Delivered by a Replication‐Defective Recombinant Adenovirus VectorThe Journal of Infectious Diseases, 2006
- CD8 T cell competition for dendritic cellsin vivois an early event in activationProceedings of the National Academy of Sciences of the United States of America, 2006
- Neutralizing Antibodies and CD8 + T Lymphocytes both Contribute to Immunity to Adenovirus Serotype 5 Vaccine VectorsJournal of Virology, 2004
- T-cell response to adenovirus hexon and DNA-binding protein in miceGene Therapy, 2004
- Replication-Deficient Human Adenovirus Type 35 Vectors for Gene Transfer and Vaccination: Efficient Human Cell Infection and Bypass of Preexisting Adenovirus ImmunityJournal of Virology, 2003
- T cell competition for the antigen-presenting cell as a model for immunodominance in the cytotoxic T lymphocyte response against minor histocompatibility antigensEuropean Journal of Immunology, 1999